Hagedorn; Peter
Patent Applications and Registrations
Patent applications and USPTO patent grants for Hagedorn; Peter.The latest application filed is for "angptl2 antisense oligonucleotides and uses thereof".
Company Profile
19.11.37
- Hagedorn; Peter - Horsholm DK
- HAGEDORN; Peter - Copenhagen DK
- Hagedorn; Peter - Seeheim-Jugenheim DE
Patent Activity
| Patent | Date |
|---|---|
| Antisense oligonucleotides targeting alpha-synuclein and uses thereof Grant 11,447,775 - Olson , et al. September 20, 2 | 2022-09-20 |
| Angptl2 Antisense Oligonucleotides And Uses Thereof App 20220213484 - ANDERSON; Brian R. ; et al. | 2022-07-07 |
| Antisense oligonucleotides targeting alpha-synuclein and uses thereof Grant 11,359,197 - Olson , et al. June 14, 2 | 2022-06-14 |
| Oligonucleotides For Modulating Tau Expression App 20220177884 - HAGEDORN; Peter ; et al. | 2022-06-09 |
| Tau Antisense Oligomers And Uses Thereof App 20220143064 - Olson; Richard E. ; et al. | 2022-05-12 |
| Alpha-synuclein Antisense Oligonucleotides And Uses Thereof App 20220119811 - HAGEDORN; Peter ; et al. | 2022-04-21 |
| Oligonucleotides for modulating ATXN2 expression Grant 11,286,485 - Hagedorn , et al. March 29, 2 | 2022-03-29 |
| Oligonucleotides for modulating Tau expression Grant 11,279,929 - Hagedorn , et al. March 22, 2 | 2022-03-22 |
| Antisense Oligonucleotides Targeting Card9 App 20220042011 - FINE; Jay ; et al. | 2022-02-10 |
| Antisense Oligonucleotides For Modulating Htra1 Expression App 20220042022 - Sanchez; Ruben Alvarez ; et al. | 2022-02-10 |
| Camk2d Antisense Oligonucleotides And Uses Thereof App 20210378652 - OLSON; Richard E. ; et al. | 2021-12-09 |
| Oligonucleotides For Modulating Myh7 Expression App 20210371860 - HAGEDORN; Peter ; et al. | 2021-12-02 |
| Tau antisense oligomers and uses thereof Grant 11,077,132 - Olson , et al. August 3, 2 | 2021-08-03 |
| Oligonucleotides for modulating ATXN2 expression Grant 11,066,669 - Hagedorn , et al. July 20, 2 | 2021-07-20 |
| CAMK2D antisense oligonucleotides and uses thereof Grant 11,058,767 - Olson , et al. July 13, 2 | 2021-07-13 |
| Antisense Oligonucleotides Targeting Alpha-Synuclein and Uses Thereof App 20210180065 - OLSON; Richard E. ; et al. | 2021-06-17 |
| Oligonucleotides For Modulating Tau Expression App 20210123054 - HAGEDORN; Peter ; et al. | 2021-04-29 |
| Oligonucleotides For Modulating Pias4 Expression App 20210095274 - HAGEDORN; Peter ; et al. | 2021-04-01 |
| Oligonucleotides For Modulating Erc1 Expression App 20210095276 - HAGEDORN; Peter ; et al. | 2021-04-01 |
| Oligonucleotides For Modulating Gsk3b Expression App 20210095275 - HAGEDORN; Peter ; et al. | 2021-04-01 |
| Oligonucleotides For Modulating Tmem106b Expression App 20210054383 - HAGEDORN; Peter ; et al. | 2021-02-25 |
| Oligonucleotides For Modulating Atxn2 Expression App 20210024925 - Hagedorn; Peter ; et al. | 2021-01-28 |
| Antisense Oligonucleotides For Modulating Htra1 Expression App 20200399641 - Iacone; Roberto ; et al. | 2020-12-24 |
| Oligonucleotides For Modulating Fndc3b Expression App 20200385714 - HAGEDORN; Peter ; et al. | 2020-12-10 |
| Antisense Oligonucleotides Targeting Alpha-synuclein And Uses Thereof App 20200362347 - OLSON; Richard E. ; et al. | 2020-11-19 |
| Antisense Oligonucleotides Targeting Alpha-synuclein And Uses Thereof App 20200354720 - OLSON; Richard E. ; et al. | 2020-11-12 |
| Chiral library screen Grant 10,815,481 - Hansen , et al. October 27, 2 | 2020-10-27 |
| Tau antisense oligomers and uses thereof Grant 10,799,523 - Olson , et al. October 13, 2 | 2020-10-13 |
| Antisense Oligonucleotides For Modulating Htra1 Expression App 20200157546 - Sanchez; Ruben Alvarez ; et al. | 2020-05-21 |
| Oligonucleotides For Modulating Atxn2 Expression App 20200024600 - Hagedorn; Peter ; et al. | 2020-01-23 |
| Oligonucleotides For Modulating Tau Expression App 20200010831 - HAGEDORN; Peter ; et al. | 2020-01-09 |
| Antisense oligonucleotides for modulating HTRA1 expression Grant 10,519,450 - Iacone , et al. Dec | 2019-12-31 |
| Methods of Selecting Therapeutic Molecules App 20190383797 - OLSON; Richard E. ; et al. | 2019-12-19 |
| Oligonucleotides For Modulating Atxn2 Expression App 20190365795 - Hagedorn; Peter ; et al. | 2019-12-05 |
| Camk2d Antisense Oligonucleotides And Uses Thereof App 20190275148 - Olson; Richard E. ; et al. | 2019-09-12 |
| Antisense Oligonucleotides For Modulating Htra1 Expression App 20190055564 - Sanchez; Ruben Alvarez ; et al. | 2019-02-21 |
| Tau Antisense Oligomers And Uses Thereof App 20180161356 - Olson; Richard E. ; et al. | 2018-06-14 |
| Stereospecific Phosphorothioate LNA App 20180112217 - Hansen; Henrik Frydenlund ; et al. | 2018-04-26 |
| Lna Oligonucleotides With Alternating Flanks App 20180023081 - HAGEDORN; Peter ; et al. | 2018-01-25 |
| LNA Gapmer Oligonucleotides Comprising Chiral Phosphorothioate Linkages App 20180016575 - Hansen; Henrik Frydenlund ; et al. | 2018-01-18 |
| Antisense Oligonucleotides For Modulating Htra1 Expression App 20180002701 - Iacone; Roberto ; et al. | 2018-01-04 |
| Chiral Library Screen App 20170335323 - Hansen; Henrik Frydenlund ; et al. | 2017-11-23 |
| Tau Antisense Oligomers and Uses Thereof App 20160237427 - OLSON; Richard E. ; et al. | 2016-08-18 |
| Diagnostic Microrna Profiling In Cutaneous T-cell Lymphoma (ctcl) App 20140272998 - Ralfkiaer; Ulrik ; et al. | 2014-09-18 |
| Markers Of Primary Graft Dysfunction App 20130252839 - Elhanan; Sahar ; et al. | 2013-09-26 |
| Openable and closable motor vehicle window Grant 6,701,673 - Kessler , et al. March 9, 2 | 2004-03-09 |
Company Registrations
| SEC | 0001247306 | HAGEDORN PETER |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 